HL7 Terminology (THO)
3.1.0 - Publication
This page is part of the HL7 Terminology (v3.1.0: Release) based on FHIR R4. The current version which supercedes this version is 5.2.0. For a full list of available versions, see the Directory of published versions
Active as of 2021-10-04 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="ca-hc-din"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This code system http://hl7.org/fhir/NamingSystem/ca-hc-din defines many codes, but they are not represented here</p></div>
</text>
<url value="http://hl7.org/fhir/NamingSystem/ca-hc-din"/>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:2.16.840.1.113883.5.1105"/>
</identifier>
<version value="4.0.0"/>
<name value="HcDIN"/>
<title value="Health Canada Drug Id Number"/>
<status value="active"/>
<experimental value="false"/>
<date value="2021-10-04T00:00:00-04:00"/>
<publisher value="Health Canada"/>
<contact>
<name value="Health Canada,Health Canada"/>
</contact>
<description
value="A Drug Identification Number (DIN) is a computer-generated eight digit number assigned by Health Canada to a drug product prior to being marketed in Canada. It uniquely identifies all drug products sold in a dosage form in Canada and is located on the label of prescription and over-the-counter drug products that have been evaluated and authorized for sale in Canada. A DIN uniquely identifies the following product characteristics:
* manufacturer
* product name
* active ingredient(s)
* strength(s) of active ingredient(s)
* pharmaceutical form, and
* route of administration.
Note: The number has a leading zero.
Further information about this Code System can be found at https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/regulatory-requirements-drug-identification-numbers/document.html"/>
<content value="not-present"/>
</CodeSystem>